Global Statins Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application
Report Code: KNJ1408864 No. of Pages: 92 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. Market Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Statins estimated at US$ 14730 million in the year 2022, is projected to reach a revised size of US$ 16430 million by 2028, growing at a CAGR of 1.8% during the forecast period 2022-2028. Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide. Report Scope This report aims to provide a comprehensive presentation of the global market for Statins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Statins. The Statins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Statins market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Statins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. Market Segmentation This report covers the Statins segments by manufacturers, by type, by application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market. By Company AstraZeneca Pfizer GlaxoSmithKline Novartis International Merck Biocon Concord Biotech Aurobindo Pharma Statins Segment by Type Astrovastatin Fluvastatin Lovastatin Pravastatin Simvastatin Others Statins Segment by Application Hospitals Clinics Statins Segment by Region North America (USA and Canada) Europe (Germany, the U.K., France, Russia, Italy, Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) South America (Mexico, Brazil, Rest of South America) Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA) Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Statins market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. Reasons to Buy This Report Informative and detailed data, sales, revenue, average price, historical and forecast data, which is analyzed to tell you why your market is set to change. Provision of market value (USD million) data for each segment and sub-segment. This report will help stakeholders to understand the global industry status and trends of Statins and provides them with information on key market drivers, restraints, challenges, and opportunities. This enables you to anticipate market changes to remain ahead of your competitors. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly. This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Statins industry. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Core Chapters Chapter One: Introduces the study scope of this report, executive summary of market segments by type, market size by type for North America, Europe, Asia Pacific, Latin America, Middle East & Africa. Chapter Two: Detailed analysis of Statins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc. Chapter Three: Sales, revenue of Statins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world. Chapter Four: Introduces market segments by application, market size by application for North America, Europe, Asia Pacific, Latin America, Middle East & Africa. Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country. Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter Twelve: Research Findings and Conclusion
1 Statins Market Overview 1.1 Statins Product Overview 1.2 Statins Market Segment by Type 1.2.1 Astrovastatin 1.2.2 Fluvastatin 1.2.3 Lovastatin 1.2.4 Pravastatin 1.2.5 Simvastatin 1.2.6 Others 1.3 Global Statins Market Size by Type 1.3.1 Global Statins Market Size Overview by Type (2017-2028) 1.3.2 Global Statins Historic Market Size Review by Type (2017-2022) 1.3.2.1 Global Statins Sales Breakdown in Volume by Type (2017-2022) 1.3.2.2 Global Statins Sales Breakdown in Value by Type (2017-2022) 1.3.2.3 Global Statins Average Selling Price (ASP) by Type (2017-2022) 1.3.3 Global Statins Forecasted Market Size by Type (2023-2028) 1.3.3.1 Global Statins Sales Breakdown in Volume by Type (2023-2028) 1.3.3.2 Global Statins Sales Breakdown in Value by Type (2023-2028) 1.3.3.3 Global Statins Average Selling Price (ASP) by Type (2023-2028) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Statins Sales Breakdown by Type (2017-2022) 1.4.2 Europe Statins Sales Breakdown by Type (2017-2022) 1.4.3 Asia-Pacific Statins Sales Breakdown by Type (2017-2022) 1.4.4 Latin America Statins Sales Breakdown by Type (2017-2022) 1.4.5 Middle East and Africa Statins Sales Breakdown by Type (2017-2022) 2 Global Statins Market Competition by Company 2.1 Global Top Players by Statins Sales (2017-2022) 2.2 Global Top Players by Statins Revenue (2017-2022) 2.3 Global Top Players Statins Price (2017-2022) 2.4 Global Top Manufacturers Statins Manufacturing Base Distribution, Sales Area, Product Type 2.5 Statins Market Competitive Situation and Trends 2.5.1 Statins Market Concentration Rate (2017-2022) 2.5.2 Global 5 and 10 Largest Manufacturers by Statins Sales and Revenue in 2021 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Statins as of 2021) 2.7 Date of Key Manufacturers Enter into Statins Market 2.8 Key Manufacturers Statins Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Statins Status and Outlook by Region 3.1 Global Statins Market Size and CAGR by Region: 2017 VS 2021 VS 2028 3.2 Global Statins Historic Market Size by Region 3.2.1 Global Statins Sales in Volume by Region (2017-2022) 3.2.2 Global Statins Sales in Value by Region (2017-2022) 3.2.3 Global Statins Sales (Volume & Value) Price and Gross Margin (2017-2022) 3.3 Global Statins Forecasted Market Size by Region 3.3.1 Global Statins Sales in Volume by Region (2023-2028) 3.3.2 Global Statins Sales in Value by Region (2023-2028) 3.3.3 Global Statins Sales (Volume & Value), Price and Gross Margin (2023-2028) 4 Global Statins by Application 4.1 Statins Market Segment by Application 4.1.1 Hospitals 4.1.2 Clinics 4.2 Global Statins Market Size by Application 4.2.1 Global Statins Market Size Overview by Application (2017-2028) 4.2.2 Global Statins Historic Market Size Review by Application (2017-2022) 4.2.2.1 Global Statins Sales Breakdown in Volume, by Application (2017-2022) 4.2.2.2 Global Statins Sales Breakdown in Value, by Application (2017-2022) 4.2.2.3 Global Statins Average Selling Price (ASP) by Application (2017-2022) 4.2.3 Global Statins Forecasted Market Size by Application (2023-2028) 4.2.3.1 Global Statins Sales Breakdown in Volume, by Application (2023-2028) 4.2.3.2 Global Statins Sales Breakdown in Value, by Application (2023-2028) 4.2.3.3 Global Statins Average Selling Price (ASP) by Application (2023-2028) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Statins Sales Breakdown by Application (2017-2022) 4.3.2 Europe Statins Sales Breakdown by Application (2017-2022) 4.3.3 Asia-Pacific Statins Sales Breakdown by Application (2017-2022) 4.3.4 Latin America Statins Sales Breakdown by Application (2017-2022) 4.3.5 Middle East and Africa Statins Sales Breakdown by Application (2017-2022) 5 North America Statins by Country 5.1 North America Statins Historic Market Size by Country 5.1.1 North America Statins Sales in Volume by Country (2017-2022) 5.1.2 North America Statins Sales in Value by Country (2017-2022) 5.2 North America Statins Forecasted Market Size by Country 5.2.1 North America Statins Sales in Volume by Country (2023-2028) 5.2.2 North America Statins Sales in Value by Country (2023-2028) 6 Europe Statins by Country 6.1 Europe Statins Historic Market Size by Country 6.1.1 Europe Statins Sales in Volume by Country (2017-2022) 6.1.2 Europe Statins Sales in Value by Country (2017-2022) 6.2 Europe Statins Forecasted Market Size by Country 6.2.1 Europe Statins Sales in Volume by Country (2023-2028) 6.2.2 Europe Statins Sales in Value by Country (2023-2028) 7 Asia-Pacific Statins by Region 7.1 Asia-Pacific Statins Historic Market Size by Region 7.1.1 Asia-Pacific Statins Sales in Volume by Region (2017-2022) 7.1.2 Asia-Pacific Statins Sales in Value by Region (2017-2022) 7.2 Asia-Pacific Statins Forecasted Market Size by Region 7.2.1 Asia-Pacific Statins Sales in Volume by Region (2023-2028) 7.2.2 Asia-Pacific Statins Sales in Value by Region (2023-2028) 8 Latin America Statins by Country 8.1 Latin America Statins Historic Market Size by Country 8.1.1 Latin America Statins Sales in Volume by Country (2017-2022) 8.1.2 Latin America Statins Sales in Value by Country (2017-2022) 8.2 Latin America Statins Forecasted Market Size by Country 8.2.1 Latin America Statins Sales in Volume by Country (2023-2028) 8.2.2 Latin America Statins Sales in Value by Country (2023-2028) 9 Middle East and Africa Statins by Country 9.1 Middle East and Africa Statins Historic Market Size by Country 9.1.1 Middle East and Africa Statins Sales in Volume by Country (2017-2022) 9.1.2 Middle East and Africa Statins Sales in Value by Country (2017-2022) 9.2 Middle East and Africa Statins Forecasted Market Size by Country 9.2.1 Middle East and Africa Statins Sales in Volume by Country (2023-2028) 9.2.2 Middle East and Africa Statins Sales in Value by Country (2023-2028) 10 Company Profiles and Key Figures in Statins Business 10.1 AstraZeneca 10.1.1 AstraZeneca Corporation Information 10.1.2 AstraZeneca Introduction and Business Overview 10.1.3 AstraZeneca Statins Sales, Revenue and Gross Margin (2017-2022) 10.1.4 AstraZeneca Statins Products Offered 10.1.5 AstraZeneca Recent Development 10.2 Pfizer 10.2.1 Pfizer Corporation Information 10.2.2 Pfizer Introduction and Business Overview 10.2.3 Pfizer Statins Sales, Revenue and Gross Margin (2017-2022) 10.2.4 Pfizer Statins Products Offered 10.2.5 Pfizer Recent Development 10.3 GlaxoSmithKline 10.3.1 GlaxoSmithKline Corporation Information 10.3.2 GlaxoSmithKline Introduction and Business Overview 10.3.3 GlaxoSmithKline Statins Sales, Revenue and Gross Margin (2017-2022) 10.3.4 GlaxoSmithKline Statins Products Offered 10.3.5 GlaxoSmithKline Recent Development 10.4 Novartis International 10.4.1 Novartis International Corporation Information 10.4.2 Novartis International Introduction and Business Overview 10.4.3 Novartis International Statins Sales, Revenue and Gross Margin (2017-2022) 10.4.4 Novartis International Statins Products Offered 10.4.5 Novartis International Recent Development 10.5 Merck 10.5.1 Merck Corporation Information 10.5.2 Merck Introduction and Business Overview 10.5.3 Merck Statins Sales, Revenue and Gross Margin (2017-2022) 10.5.4 Merck Statins Products Offered 10.5.5 Merck Recent Development 10.6 Biocon 10.6.1 Biocon Corporation Information 10.6.2 Biocon Introduction and Business Overview 10.6.3 Biocon Statins Sales, Revenue and Gross Margin (2017-2022) 10.6.4 Biocon Statins Products Offered 10.6.5 Biocon Recent Development 10.7 Concord Biotech 10.7.1 Concord Biotech Corporation Information 10.7.2 Concord Biotech Introduction and Business Overview 10.7.3 Concord Biotech Statins Sales, Revenue and Gross Margin (2017-2022) 10.7.4 Concord Biotech Statins Products Offered 10.7.5 Concord Biotech Recent Development 10.8 Aurobindo Pharma 10.8.1 Aurobindo Pharma Corporation Information 10.8.2 Aurobindo Pharma Introduction and Business Overview 10.8.3 Aurobindo Pharma Statins Sales, Revenue and Gross Margin (2017-2022) 10.8.4 Aurobindo Pharma Statins Products Offered 10.8.5 Aurobindo Pharma Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Statins Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Statins Industrial Chain Analysis 11.4 Statins Market Dynamics 11.4.1 Statins Industry Trends 11.4.2 Statins Market Drivers 11.4.3 Statins Market Challenges 11.4.4 Statins Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Statins Distributors 12.3 Statins Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com